SK pharmteco Invests $6.1 Million to Expand U.S. Peptide Manufacturing Capabilities in California

SK pharmteco, a global contract development and manufacturing organization (CDMO), announced today a $6.1 million investment in its Rancho Cordova facili...

October 24, 2025 | Friday | News
Abzena Grants Orion Exclusive License to CHAb™-Designed Antibody Targeting High-Unmet-Need Cancer

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced that Orion has obtained an exclusive focused commercial...

October 24, 2025 | Friday | News
Syngene Strengthens India’s Biologics Leadership with New GMP Bioconjugation Suite in Bengaluru

Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commerci...

October 23, 2025 | Thursday | News
ProImmune Expands UK Operations with New Global Headquarters at Oxford’s Oasis Park

Move follows ProImmune’s recent acquisition of Oasis Park a 70,000 sq ft Business and Light Industrial Park in Oxford, UK Increased operationa...

October 23, 2025 | Thursday | News
BriaCell Partners with Memorial Sloan Kettering to Accelerate Development of Next-Generation Personalized Immunotherapy

Collaboration with MSK’s Therapeutics Accelerator Program includes manufacturing, IND and clinical development support of the Bria-OTS+™ pl...

October 22, 2025 | Wednesday | News
Agarose Bead Technologies Marks 25 Years with $10 Million Expansion and Global Growth Strategy

Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins has announced plans for further expansion, reinforcing its positio...

October 22, 2025 | Wednesday | News
Genentech’s Gazyva® Receives FDA Approval for the Treatment of Lupus Nephritis in Adults

 The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus n...

October 21, 2025 | Tuesday | News
Adcytherix Raises €105 Million Series A to Advance Next-Generation Antibody–Drug Conjugates with Novel Payloads

Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads Financing led b...

October 20, 2025 | Monday | News
Forlong Biotechnology Receives First Milestone Payment for Fbody®-Based Fusion Protein Therapy Following IND Submission in China

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, to...

October 15, 2025 | Wednesday | News
Quotient Sciences and Biorasi Partner to Streamline Early Clinical Trials from IND to Proof-of-Concept

Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Biorasi, a global clinical research organization (CRO),...

October 15, 2025 | Wednesday | News
Daiichi Sankyo Showcases Transformative ADC Data at ESMO 2025

Back-to-back Presidential Symposium presentations of ENHERTU from DESTINY-Breast11 and DESTINY-Breast05 demonstrate its potential to become a foundat...

October 14, 2025 | Tuesday | News
IDT and Hamilton Partner to Automate Next-Generation Sequencing Workflows for Global Genomic Research

To equip users with a complete next generation sequencing (NGS) solution from sample to answer, global genomics leader Integrated DNA Technologies (IDT),...

October 14, 2025 | Tuesday | News
Bicara Therapeutics’ Ficerafusp Alfa Receives FDA Breakthrough Therapy Designation for HPV-Negative Head and Neck Cancer

Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patien...

October 14, 2025 | Tuesday | News
ABLi Therapeutics Announces Positive Phase 2 Results for Risvodetinib in Untreated Parkinson’s Disease

ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosin...

October 10, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close